Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Verastem Oncology (VSTM) has a market cap of $0.25 billion USD. According to our data, Verastem Oncology is ranked No.6892 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.25 B |
6.77%
|
| Dec 31, 2024 | $0.23 B |
-36.49%
|
| Dec 29, 2023 | $0.36 B |
69.58%
|
| Dec 30, 2022 | $0.21 B |
-80.49%
|
| Dec 31, 2021 | $1.09 B |
-3.76%
|
| Dec 31, 2020 | $1.14 B |
58.96%
|
| Dec 31, 2019 | $0.72 B |
-60.12%
|
| Dec 31, 2018 | $1.79 B |
9.45%
|
| Dec 29, 2017 | $1.64 B |
174.11%
|
| Dec 30, 2016 | $0.60 B |
-39.78%
|
| Dec 31, 2015 | $0.99 B |
-79.65%
|
| Dec 31, 2014 | $4.88 B |
-19.82%
|
| Dec 31, 2013 | $6.09 B |
29.69%
|
| Dec 31, 2012 | $4.69 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
 Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
 Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
 Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
 Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
 Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
 Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
 BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
| Market Cap | = | VSTM Stock Price | * | VSTM Shares Outstanding |
| = | $5.52 | * | 44.51 M | |
| = | $0.25 B |